Integer Holdings Corporation Income Statement 2011-2026 | ITGR

Annual Income Statement Integer Holdings Corporation

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.98 B	4.58 B	3.34 B	2.44 B	2.77 B	2.9 B	2.86 B	2.61 B	1.63 B	1.02 B	1.26 B	1.08 B	-	639 M	539 M
Shares	34.7 M	33.6 M	33.3 M	33.1 M	33 M	32.8 M	32.6 M	32.6 M	32.1 M	26.4 M	26 M	25.3 M	-	23.6 M	23.6 M
Historical Prices	85.7	136	100	73.6	83.9	88.2	90.2	91	51	36.1	37.8	53.1	43.3	27.1	24.8
Net Income	103 M	120 M	90.6 M	66.4 M	96.8 M	77.3 M	96.3 M	168 M	66.7 M	-7.59 M	55.5 M	36.3 M	-	-4.8 M	33.1 M
Revenue	1.85 B	1.72 B	1.56 B	1.33 B	1.22 B	1.07 B	1.26 B	1.22 B	1.14 B	800 M	688 M	664 M	-	646 M	569 M
Cost of Revenue	1.35 B	1.26 B	1.15 B	986 M	884 M	788 M	903 M	852 M	782 M	738 M	456 M	445 M	-	445 M	388 M
Gross Profit	500 M	459 M	410 M	346 M	337 M	286 M	355 M	363 M	354 M	235 M	231 M	219 M	-	202 M	180 M
Operating Income	221 M	208 M	163 M	113 M	136 M	121 M	158 M	156 M	126 M	92.9 M	75.7 M	61.3 M	-	25.8 M	61.7 M
Interest Expense	-53.2 M	-3.52 M	-975 K	899 K	31.6 M	38.2 M	52.5 M	99.3 M	64 M	68.3 M	4.25 M	11.3 M	-	18.1 M	16.9 M
EBITDA	352 M	319 M	262 M	205 M	217 M	200 M	244 M	278 M	228 M	57.8 M	113 M	97.3 M	-	72.2 M	109 M
Operating Expenses	279 M	251 M	247 M	233 M	201 M	165 M	189 M	173 M	228 M	222 M	156 M	158 M	-	176 M	119 M
General and Administrative Expenses	212 M	185 M	173 M	158 M	141 M	109 M	139 M	116 M	120 M	92.8 M	83.6 M	82.3 M	-	74.8 M	72.5 M

All numbers in USD currency

Quarterly Income Statement Integer Holdings Corporation

	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	35.1 M	35 M	33.9 M	33.5 M	33.7 M	33.6 M	33.5 M	33.3 M	33.3 M	33.3 M	33.3 M	33.2 M	33.1 M	33.1 M	33.1 M	33.1 M	33 M	33 M	33 M	32.9 M	32.9 M	32.8 M	32.8 M	32.7 M	32.7 M	32.6 M	32.5 M	32.5 M	32.2 M	32 M	31.9 M	31.9 M	31.6 M	31.3 M	31 M	30.9 M	30.8 M	30.8 M	30.7 M	25.1 M	25.5 M	25.5 M	25.3 M	24.4 M	24.9 M	24.8 M	24.6 M	-	24 M	23.9 M	23.8 M	23.7 M	23.6 M	23.6 M	23.4 M	23.4 M	23.3 M	23.2 M	23.2 M
Net Income	39.7 M	37 M	-22.5 M	-	35.4 M	31.2 M	20.5 M	-	27.3 M	24 M	13.1 M	-	16.1 M	20.8 M	11.4 M	-	22.1 M	29.4 M	21.5 M	-	30.3 M	389 K	31.1 M	11 M	30.6 M	33.1 M	21.7 M	19.2 M	-8.3 M	23.1 M	13.1 M	54.7 M	19.9 M	9.56 M	2.95 M	7.93 M	11.5 M	-770 K	-12.7 M	14.2 M	22 K	9.28 M	8.01 M	9.78 M	14 M	12.3 M	14.9 M	-	11.1 M	9.75 M	5.66 M	-5.56 M	-7.56 M	3.85 M	4.47 M	5.64 M	6.99 M	8.55 M	11.9 M
Revenue	468 M	476 M	437 M	-	431 M	428 M	408 M	-	397 M	400 M	379 M	-	343 M	350 M	311 M	-	306 M	312 M	290 M	269 M	236 M	240 M	328 M	326 M	304 M	314 M	315 M	303 M	305 M	314 M	382 M	390 M	363 M	281 M	345 M	360 M	347 M	348 M	332 M	170 M	147 M	175 M	161 M	177 M	172 M	172 M	174 M	-	168 M	171 M	148 M	159 M	161 M	167 M	159 M	142 M	132 M	147 M	149 M
Cost of Revenue	342 M	347 M	317 M	-	315 M	311 M	300 M	-	292 M	294 M	282 M	-	256 M	257 M	229 M	-	224 M	223 M	206 M	-	178 M	182 M	232 M	-	210 M	217 M	226 M	-	213 M	216 M	209 M	-	197 M	192 M	254 M	-	249 M	252 M	241 M	-	95 M	117 M	109 M	-	114 M	114 M	117 M	-	112 M	114 M	99.5 M	-	110 M	115 M	112 M	-	89.8 M	99.9 M	102 M
Gross Profit	126 M	129 M	120 M	-	117 M	117 M	108 M	-	105 M	106 M	96.7 M	-	86.7 M	92.9 M	81.5 M	-	81.9 M	88.7 M	84.5 M	73.2 M	57.9 M	57.9 M	96.7 M	76 M	93.4 M	97 M	88.6 M	88.4 M	91.9 M	98.8 M	83.5 M	93.6 M	89.2 M	89.2 M	82 M	92.9 M	97.9 M	96 M	91.5 M	57.2 M	51.6 M	58 M	52.4 M	57.4 M	58.1 M	58.5 M	57.6 M	-	55.9 M	57.3 M	48.7 M	51.9 M	51 M	51.9 M	46.9 M	44.7 M	41.9 M	46.6 M	47.2 M
Operating Income	56.4 M	59.3 M	49.6 M	-	58 M	54.5 M	38.7 M	-	48.8 M	41.6 M	34.2 M	-	29.3 M	32.7 M	22.5 M	-	33.1 M	39.4 M	34.6 M	-	39.8 M	9.18 M	44.1 M	-	46.5 M	49.3 M	39.2 M	-	41.5 M	44.4 M	30 M	-	35.8 M	36.1 M	26.5 M	-	36.9 M	29.3 M	11.1 M	-	1.2 M	13 M	9.39 M	-	16.2 M	19.5 M	22.5 M	-	17 M	17.1 M	14.3 M	-	2.13 M	11.1 M	11.2 M	-	12.9 M	18.3 M	18 M
Interest Expense	-1.13 M	-3.98 M	-47.9 M	-	-916 K	127 K	-1.01 M	-	-580 K	-359 K	17.3 M	-	10.7 M	7.77 M	5.97 M	-	10.1 M	7.53 M	8.53 M	-	9.37 M	9.27 M	10.4 M	-	12.3 M	13.6 M	13.8 M	-	54.5 M	15.2 M	15.6 M	-	15.8 M	15.1 M	28.9 M	-	27.9 M	27.9 M	27.6 M	-	5.82 M	1.21 M	1.12 M	-	1.05 M	1.07 M	1.08 M	-	1.52 M	1.44 M	6.99 M	-	4.4 M	4.42 M	4.36 M	-	4.12 M	4.4 M	4.27 M
EBITDA	72.7 M	75.5 M	79.4 M	-	71.6 M	68.1 M	64.9 M	-	61.8 M	54.7 M	58.3 M	-	41.4 M	45 M	45 M	-	93.6 M	49.7 M	54.9 M	-	98.8 M	48.3 M	63.6 M	-	104 M	87.9 M	58.8 M	-	110 M	92.9 M	56.4 M	-	110 M	85.5 M	51.2 M	-	104 M	74.3 M	33.5 M	-	28.1 M	31.2 M	18.6 M	-	44.1 M	38.1 M	31.8 M	-	43.7 M	35 M	23.1 M	-	36.2 M	33.2 M	22.3 M	-	40 M	36.3 M	26.8 M
Operating Expenses	69.7 M	69.8 M	70.8 M	-	58.6 M	62.9 M	69.6 M	-	56.2 M	64.2 M	62.5 M	-	57.5 M	60.2 M	59 M	-	48.8 M	49.4 M	49.9 M	-	18.2 M	48.7 M	52.6 M	-	46.9 M	47.6 M	49.4 M	-	50.5 M	54.4 M	53.5 M	-	53.4 M	53.1 M	64.7 M	-	61 M	66.8 M	80.3 M	-	50.5 M	44.9 M	43 M	-	41.9 M	38.9 M	35.1 M	-	38.9 M	40.2 M	34.4 M	-	48.8 M	40.8 M	35.7 M	-	29 M	28.3 M	29.2 M
General and Administrative Expenses	50.5 M	52.9 M	51.2 M	-	44.8 M	46.5 M	46.4 M	-	41.4 M	45.8 M	41.9 M	-	38.2 M	41.8 M	39.6 M	-	34.3 M	35.4 M	35.5 M	-	3.61 M	33.9 M	36.5 M	-	32.9 M	33.1 M	35 M	-	34.1 M	36.8 M	36.4 M	-	35.1 M	35.1 M	39.5 M	-	36.3 M	37.6 M	41.9 M	-	22.3 M	24.1 M	22.6 M	-	22.1 M	21.9 M	21.8 M	-	21.6 M	22.2 M	20.1 M	-	20.3 M	20.7 M	19 M	-	17.8 M	17.6 M	18.6 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company Integer Holdings Corporation (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

How much revenue the company earned
How much it spent on production, personnel, marketing, taxes, etc.
What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features

The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer	Price	% 24h	Market Cap	Country
Butterfly Network BFLY	$ 4.2	0.24 %	$ 889 M	USA
GenMark Diagnostics, Inc. GNMK	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	-	-	$ 3.31 B	USA
Lianluo Smart Limited LLIT	-	24.59 %	$ 44.8 M	China
Aziyo Biologics AZYO	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	-	-5.86 %	$ 30.6 M	USA
BioSig Technologies BSGM	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	-	0.15 %	$ 844 M	USA
LivaNova PLC LIVN	$ 62.85	-0.62 %	$ 3.43 B	Britain
Apollo Endosurgery APEN	-	-	$ 475 M	USA
LENSAR LNSR	$ 6.01	-0.99 %	$ 69.2 M	USA
Delcath Systems DCTH	$ 9.02	-0.88 %	$ 323 M	USA
Avinger AVGR	-	-20.74 %	$ 369 K	USA
CryoLife, Inc. CRY	-	-4.14 %	$ 702 M	USA
CHF Solutions, Inc. CHFS	-	1.15 %	$ 34.5 M	USA
Medtronic PLC MDT	$ 86.6	-0.7 %	$ 111 B	USA
AxoGen AXGN	$ 31.55	-0.63 %	$ 1.45 B	USA
CONMED Corporation CNMD	$ 36.63	-	$ 1.14 B	USA
Soliton, Inc. SOLY	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-	0.03 %	$ 1.58 B	Israel
Electromed ELMD	$ 24.03	-1.88 %	$ 203 M	USA
Misonix, Inc. MSON	-	-	$ 462 M	USA
Neovasc NVCN	-	-	$ 111 M	Canada
Intersect ENT, Inc. XENT	-	-	$ 955 M	USA
Myomo MYO	$ 0.7	-0.79 %	$ 29.3 M	USA
Cytosorbents Corporation CTSO	$ 0.67	-	$ 36.5 M	USA
Aethlon Medical AEMD	$ 2.2	-4.34 %	$ 3.43 M	USA
BIOLASE BIOL	-	-13.19 %	$ 166 K	USA
Nano-X Imaging Ltd. NNOX	$ 2.39	-2.05 %	$ 140 M	Israel
AdaptHealth Corp. AHCO	$ 10.61	2.31 %	$ 1.43 B	USA
Orthofix Medical OFIX	$ 11.76	-0.93 %	$ 466 M	Curacao
IRadimed Corporation IRMD	$ 98.85	-0.35 %	$ 1.26 B	USA
Outset Medical OM	$ 3.56	-1.66 %	$ 54.2 K	USA
Invacare Corporation IVC	-	-	$ 24.7 M	USA
EDAP TMS S.A. EDAP	$ 3.73	-	$ 139 M	France
Varex Imaging Corporation VREX	$ 10.66	-1.48 %	$ 441 M	USA
OrthoPediatrics Corp. KIDS	$ 16.3	-1.03 %	$ 382 M	USA
Penumbra PEN	$ 334.77	-0.24 %	$ 13 B	USA
Inspire Medical Systems INSP	$ 51.01	-2.3 %	$ 1.5 B	USA
Insulet Corporation PODD	$ 222.59	-1.98 %	$ 15.7 B	USA
Profound Medical Corp. PROF	$ 5.36	-0.74 %	$ 180 M	Canada
Pulmonx Corporation LUNG	$ 1.35	-3.24 %	$ 54.9 M	USA
Quanterix Corporation QTRX	$ 3.87	-1.78 %	$ 165 M	USA
Cutera CUTR	-	-10.19 %	$ 1.99 M	USA
Dynatronics Corporation DYNT	-	14.99 %	$ 929 K	USA
InspireMD NSPR	$ 1.75	0.87 %	$ 113 M	Israel

Integer Holdings Corporation Income Statement 2011-2026 | ITGR

Annual Income Statement Integer Holdings Corporation

Market Cap

Shares

Historical Prices

Net Income

Revenue

Cost of Revenue

Gross Profit

Operating Income

Interest Expense

EBITDA

Operating Expenses

General and Administrative Expenses